Nonradioactive in situ hybridization in progressive multifocal leukoencephalopathy

Area of Science:

• Neurovirology
• Molecular Pathology
• Diagnostic Techniques

Background:

• Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease often associated with impaired cell-mediated immunity.
• JC virus (JCV) is the causative agent of PML, and its detection in brain tissue is crucial for diagnosis.
• Traditional diagnostic methods may have limitations in sensitivity or specificity.

Purpose of the Study:

• To evaluate the utility of biotinylated DNA:DNA in situ hybridization for detecting JC virus in brain tissues of patients with suspected PML.
• To correlate the presence of JCV with pathological changes at the cellular level.
• To assess the applicability of the technique to archival and biopsy specimens.

Main Methods:

• Biotinylated DNA:DNA in situ hybridization was performed on brain tissues from 67 patients with suspected PML.
• The technique utilized biotinylated probes to detect JC virus DNA.
• Cellular pathology, including changes in oligodendrocytes and astrocytes, was examined in conjunction with viral detection.

Main Results:

• The in situ hybridization method demonstrated specificity and ease of interpretation.
• JC virus DNA was detected in brain tissues, with an average of 1,000 copies per nucleus in infected cells.
• The technique successfully identified infected cells even in small biopsy specimens and correlated viral presence with pathological changes.

Conclusions:

• Biotinylated DNA:DNA in situ hybridization is a sensitive and specific method for diagnosing PML by detecting JC virus in brain tissue.
• The technique allows for single-cell level correlation of viral presence with neuropathology.
• This method is valuable for evaluating both archival and fresh biopsy samples, serving as a useful adjunctive diagnostic procedure.